Purpose: We evaluated the safety and efficacy of 80 W potassium-titanyl-phosphate (KTP) laser vaporization of the prostate in men with prostate volumes >70 ml. Materials and Methods: Laser vaporization of the prostate with an 80 W KTP laser was applied between September 2003 and April 2005. Preoperative evaluation of 100 patients included the International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), postvoid residual urine volume (PVR), prostate volume, serum sodium, creatinine, hemoglobin, prostate-specific antigen and urinalysis. Results: The mean age of the patients, mean volume of the prostates, mean operative time and mean energy delivery were 67.0 ± 7.9 (53–90) years, 98.2 ± 18.9 (74–170) ml, 150.1 ± 22.7 (100–240) min and 246.1 ± 77.8 (100–500) kJ, respectively. The serum sodium, creatinine and hemoglobin levels did not change significantly. Urinary retention requiring recatheterization was detected in 10 patients. There was moderate dysuria in 22 patients with a mean duration of 2 months and mild hematuria in 16 patients with a mean duration of 1 month postoperatively. Urinary tract infection occurred in 5 patients. We observed clot retention in 2 patients. The IPSS, Qmax and PVR values had significantly improved by postoperative months 1, 3, 6 and 12. Reoperation was performed in 5 patients. Internal urethrotomy was performed in 1 patient with bladder neck contracture. Conclusions: 80 W KTP laser vaporization is a virtually bloodless, safe and effective procedure for surgical treatment of large volume prostates.

Keywords:
KTP laser, Large prostate, Benign prostatic hyperplasia
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.